CVS Health Co. (NYSE:CVS) Shares Purchased by Jump Financial LLC

Jump Financial LLC grew its stake in CVS Health Co. (NYSE:CVS - Free Report) by 3,329.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 342,903 shares of the pharmacy operator's stock after buying an additional 332,903 shares during the quarter. Jump Financial LLC's holdings in CVS Health were worth $15,393,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Norges Bank acquired a new position in CVS Health during the fourth quarter worth $839,574,000. Davis Selected Advisers lifted its holdings in shares of CVS Health by 2,998.1% in the fourth quarter. Davis Selected Advisers now owns 11,385,950 shares of the pharmacy operator's stock valued at $511,115,000 after purchasing an additional 11,018,438 shares in the last quarter. Pzena Investment Management LLC increased its stake in shares of CVS Health by 49.3% during the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock worth $880,319,000 after purchasing an additional 6,475,271 shares in the last quarter. Invesco Ltd. lifted its stake in shares of CVS Health by 30.1% during the fourth quarter. Invesco Ltd. now owns 18,038,089 shares of the pharmacy operator's stock valued at $809,730,000 after buying an additional 4,173,243 shares during the period. Finally, Raymond James Financial Inc. purchased a new stake in CVS Health in the 4th quarter valued at about $116,033,000. Institutional investors and hedge funds own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on CVS shares. Wells Fargo & Company boosted their target price on shares of CVS Health from $68.00 to $73.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. Mizuho boosted their price target on shares of CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Wolfe Research raised their price objective on CVS Health from 67.00 to 70.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 11th. Truist Financial boosted their target price on CVS Health from $76.00 to $82.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Finally, Piper Sandler lifted their target price on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research report on Friday, March 21st. Four research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, CVS Health has an average rating of "Moderate Buy" and a consensus target price of $71.83.

Insider Buying and Selling

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The shares were purchased at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the acquisition, the director now owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. This represents a 47.23 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.24% of the company's stock.

CVS Health Price Performance

CVS Health stock traded down $1.37 during midday trading on Friday, reaching $67.19. The company's stock had a trading volume of 16,054,208 shares, compared to its average volume of 11,811,363. The stock's 50 day simple moving average is $66.46 and its 200 day simple moving average is $58.79. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The firm has a market capitalization of $84.71 billion, a PE ratio of 18.36, a P/E/G ratio of 0.98 and a beta of 0.57. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $71.45.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, equities research analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.96%. The ex-dividend date of this dividend is Tuesday, April 22nd. CVS Health's dividend payout ratio (DPR) is presently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.